Parathyroid Diseases: Clinical Trials

7 trials for Parathyroid Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 unknown, 1 recruiting, 1 suspended. 7 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 17Completed 3, Unknown 2, Recruiting 1, Suspended 1

Follow Parathyroid Diseases: new trials by email Literature Review of Parathyroid Diseases trials Research Report on Parathyroid Diseases

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Flurpiridaz F-18 PET/CT Imaging for Detecting Parathyroid Adenomas
Flurpiridaz PET/CT - Hyperparathyroidism
Early Phase 1RecruitingUniversity of Pennsylvania202026-08-152026-11-02
Efficacy and Safety of XH02 for the Treatment of Hypoparathyroidism
intravenous administration of PTH1-84 mRNA - Hypoparathyroidism
Early Phase 1SuspendedPeking Union Medical College Hospital62025-05-202026-10-16
Diagnostic Accuracy Study of Indocyanine Green for Perfusion Assessment
Indocyanine Green near infrared fluorescence imaging - Hypoparathyroidism
Early Phase 1CompletedUniversity Medical Center Groningen802020-11-052024-09-19
Exparel Injection Effect on Postoperative Opioid Usage
Lidocaine Epinephrine, Bupivacaine Hydrochloride-EPINEPHrine, Lidocaine Epinephrine, Bupivacaine Hydrochloride-EPINEPHrine - Thyroid, Parathyroid Adenoma
Early Phase 1UnknownUniversity of Missouri-Columbia1002019-09-302024-07-29
Corticosteroid Rhythms in Hypoparathyroid Patients
parathyroid hormon 1-84 - Hypoparathyroidism, Hyperparathyroidism
Early Phase 1UnknownUniversity of Bergen302016-03-012017-10-27
One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study
PTHrP (1-36) - Osteoporosis, Humoral Hypercalcemia of Malignancy
Early Phase 1CompletedUniversity of Pittsburgh142008-01-012016-02-11
7 Day Continuous Parathyroid Hormone IV Infusion
Parathyroid Hormone (1-34) - Osteoporosis, Bone Diseases, Endocrine
Early Phase 1CompletedUniversity of Pittsburgh112006-09-012016-03-22

Narrower conditions

Hyperparathyroidism (4)  ·  Hypoparathyroidism (3)  ·  Endocrine System Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Osteoporosis (2)  ·  Bone Diseases, Endocrine (1)  ·  Humoral Hypercalcemia Of Malignancy (1)  ·  Neoplasms (1)  ·  Parathyroid Neoplasms (1)  ·  Thyroid Diseases (1)

Broader conditions

Endocrine System Diseases (5)  ·  Bone Diseases (2)  ·  Bone Diseases, Metabolic (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Endocrine Gland Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)

Interventions

Parathyroid Hormone (2)  ·  Root Cause Analysis (1)  ·  parathyroid hormone-related peptide (1-36) (1)

Sponsors

University of Pittsburgh (2)  ·  Peking Union Medical College Hospital (1)  ·  University Medical Center Groningen (1)  ·  University of Bergen (1)  ·  University of Missouri-Columbia (1)  ·  University of Pennsylvania (1)

Countries

United States (4)  ·  China (1)  ·  Netherlands (1)  ·  Norway (1)

Top investigators

Eystein Husebye, Professor (1)  ·  Mara J Horwitz, MD (1)  ·  Mara J. Horwitz, MD (1)  ·  Schelto Kruijff, Professor (1)  ·  Tabitha Galloway, MD (1)  ·  Victor Babatunde, MD (1)

Results publications

PMID 21544866, PMID 39167533

NIH funding

R01DK073039 (2)